Weekly digest: EU clinical trial registry, data sharing and Ipsen’s commitment to PLS

Luke Bratton

This week, we see the launch of the EU clinical trial registry and an open access agreement for Irish institutions as well as learning about the benefits and risks of public sector data sharing. We look forward to the rest of 2022 with the five big trends to look out for in scholarly publishing and with a summary of insights from the 2022 European Meeting of ISMPP. Finally, we hear a discussion of Ipsen’s commitment to plain language summaries and highlight how you can write and publish your own.

To read:

Mandatory publication of clinical trial results in 30 European countries via TranspariMED | 6-minute read

The launch of a new clinical trial registry by the EU marks the introduction of legal obligations for companies, universities and hospitals to provide public access to clinical trial results within 1 year of trial completion. This move brings the EU Clinical Trial Regulation into full effect and more closely aligns Europe with World Health Organization best practices for the public disclosure of results from clinical trials.

Public health sector data sharing: benefits, risks and barriers via UK Parliament | 4-minute read

The UK’s Parliamentary Office of Science and Technology recently published a research briefing looking at how public data is shared and the challenges and benefits associated with data sharing. It is estimated that around £130 million is added to London’s economy every year thanks to the freely available data published by Transport for London. There are, however, questions about how to work with data protection requirements effectively, and whether open access to health data might deter people from seeking medical treatment.

2022 ISMPP European Meeting: Day 1 via The Publication Plan | 20-minute read

The 2022 International Society for Medical Publication Professionals (ISMPP) European Meeting took place on 25–26 January. Topics covered on Day 1 of the online meeting included: how to continue building and maintaining trust in the medical communications industry; upcoming initiatives to support transparent medical publications development; and how the COVID-19 pandemic impacted the health and well-being of publication professionals and taught us the importance of compassionate leadership.

Five trends in scholarly publishing to watch in 2022 via Scholastica | 8-minute read

With a focus on small to mid-size independent publishers, this Scholastica blog highlights the five big scholarly publishing trends to look out for in 2022. These are: the widening reach of the open science movement; the increase in access to open data; the increase in sustainable publishing practices; the rise of novel methods for assessing research; and the rise of persistent identifiers, such as ORCID iDs.

A new agreement waives open access publishing charges for authors at Irish institutions via IReL and PLOS Blogs | 3-minute read

PLOS and the Irish Library Consortium (IReL) have announced a new 3-year open access publishing agreement. Under this new agreement, which runs from 1 February 2022 to 31 December 2024, there will be no author-facing charges for eligible authors from Irish institutions for articles accepted for publication in a number of PLOS journals.

How to write and publish plain language summaries in 10 steps via iTech Post | 9-minute read

Since 2020, Future Science Group journals have advocated the use of plain language summaries (PLS) to broaden access to information related to the latest tech, treatments and therapies in medicine. Demand for easily digestible summaries is on the rise, and this article provides an overview for any authors looking to use PLS to make their research more accessible.

To listen to:

Ipsen commit to publishing plain language summaries: what it means for patients, publishers and physicians via Velocity of Content | 28-minute listen

Ipsen recently became the first pharmaceutical company to commit to publishing plain language summaries for all their journal publications that include data from human participants. In this podcast from the Copyright Clearance Center, we hear from Ipsen Global Patient Centricity Director Oleksandr Gorbenko, Future Science Group Head of Publishing Solutions Joanne Walker and Oxford PharmaGenesis Medical Writer Adeline Rosenberg as they discuss the implications of plain language summaries for patients, publishers and physicians.

Have you read our recommendations for plain language summaries of peer-reviewed medical journal publications? Find out more here and join the discussion on social media using the hashtag #PlainLanguageSummaries!